Bio Rad Laboratories Inc stock is traded at $367.50, with a volume of 424,363. It is down -0.72% in the last 24 hours and up +4.16% over the past month. Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Previous Close:
$370.17
Open:
$373.35
24h Volume:
424,363
Relative Volume:
1.44
Market Cap:
$9.88B
Revenue:
$2.59B
Net Income/Loss:
$168.80M
P/E Ratio:
60.50
EPS:
$6.07
Net Cash Flow:
$357.20M
1W Performance:
-0.80%
1M Performance:
+4.16%
6M Performance:
+30.76%
1Y Performance:
+20.57%
1-Day Range:
$366.69$382.55
1-Week Range:
$356.50$382.55
52-Week Range:
$236.73$396.23
Bio Rad Laboratories Inc Stock (BIO) Company Profile
Name
Bio Rad Laboratories IncSector
HealthcareIndustry
Medical DevicesPhone
(510) 724-7000Address
1000 ALFRED NOBEL DRIVE, HERCULES, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS